Income Statement (TTM)
Arbutus Biopharma Corporation Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 7 | 8 | 8 | 10 | 11 | 21 | 33 | 36 | 39 | 33 | 24 | 22 | 18 | 13 | 10 | 7 | 6 | 6 | 15 |
| Change (%) | 12.50 | 9.00 | 10.81 | 21.76 | 8.06 | 95.27 | 55.52 | 7.83 | 8.45 | -15.11 | -28.95 | -5.50 | -18.43 | -28.42 | -22.52 | -32.99 | -8.47 | 3.76 | 140.76 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 45 | 49 | 53 | 58 | 63 | 66 | 70 | 77 | 81 | 84 | 84 | 79 | 79 | 74 | 71 | 40 | 34 | 54 | 48 | 53 |
| Change (%) | 8.76 | 6.82 | 10.12 | 8.00 | 4.50 | 7.14 | 10.18 | 4.33 | 4.63 | -0.22 | -6.23 | 0.14 | -6.81 | -3.90 | -43.68 | -14.78 | 58.95 | -11.93 | 10.95 | |
| % of Revenue | 738.11 | 713.60 | 699.36 | 694.98 | 616.46 | 596.12 | 327.10 | 231.73 | 224.21 | 216.33 | 254.25 | 335.55 | 355.58 | 406.26 | 545.42 | 396.51 | 504.26 | 875.66 | 743.29 | 342.54 |
| Gross Operating Profit | -39 | -42 | -45 | -50 | -53 | -55 | -49 | -44 | -45 | -45 | -51 | -55 | -57 | -56 | -58 | -30 | -27 | -48 | -41 | -37 |
| Change (%) | 8.17 | 6.47 | 10.00 | 5.69 | 3.81 | -10.62 | -9.79 | 1.67 | 1.56 | 12.57 | 8.49 | 2.54 | -2.26 | 4.11 | -48.43 | -8.64 | 75.62 | -13.95 | -9.23 | |
| % of Revenue | -638.11 | -613.60 | -599.36 | -594.98 | -516.46 | -496.12 | -227.10 | -131.73 | -124.21 | -116.33 | -154.25 | -235.55 | -255.58 | -306.26 | -445.42 | -296.51 | -404.26 | -775.66 | -643.29 | -242.54 |
| SG&A | 13 | 15 | 15 | 16 | 16 | 17 | 18 | 19 | 18 | 18 | 18 | 19 | 22 | 22 | 22 | 24 | 22 | 26 | 26 | 22 |
| Change (%) | 13.66 | 2.19 | 6.01 | 0.73 | 5.78 | 5.92 | 3.98 | -3.66 | -1.91 | 3.70 | 4.22 | 12.19 | 3.94 | -1.07 | 7.05 | -5.48 | 14.81 | 2.01 | -16.01 | |
| % of Revenue | 212.51 | 214.71 | 201.30 | 192.58 | 159.32 | 155.95 | 84.59 | 56.56 | 50.53 | 45.71 | 55.83 | 81.90 | 97.22 | 123.89 | 171.22 | 236.58 | 333.68 | 418.54 | 411.49 | 143.55 |
| R&D | 29 | 29 | -15 | |||||||||||||||||
| Change (%) | 0.00 | |||||||||||||||||||
| % of Revenue | 286.19 | 427.08 | -99.03 | |||||||||||||||||
| OpEx | 60 | 64 | 67 | 73 | 77 | 83 | 88 | 96 | 99 | 102 | 103 | 98 | 101 | 96 | 93 | 92 | 85 | 80 | 74 | 60 |
| Change (%) | 6.22 | 4.97 | 8.53 | 5.84 | 6.78 | 6.89 | 8.90 | 2.76 | 3.43 | 0.46 | -4.35 | 2.51 | -4.50 | -3.24 | -0.62 | -7.79 | -6.36 | -7.42 | -19.30 | |
| % of Revenue | 983.13 | 928.30 | 894.03 | 875.57 | 761.12 | 752.07 | 411.69 | 288.29 | 274.74 | 262.03 | 310.08 | 417.44 | 452.80 | 530.15 | 716.64 | 919.28 | 1,265.03 | 1,294.20 | 1,154.79 | 387.06 |
| Operating Income | -54 | -57 | -60 | -65 | -67 | -72 | -67 | -63 | -63 | -63 | -70 | -75 | -78 | -78 | -80 | -82 | -79 | -74 | -68 | -44 |
| Change (%) | 5.51 | 4.49 | 8.24 | 3.79 | 6.59 | -6.66 | -6.05 | 0.07 | 0.56 | 10.07 | 7.36 | 5.03 | -0.55 | 2.62 | 2.94 | -4.71 | -6.18 | -8.35 | -34.48 | |
| % of Revenue | -883.13 | -828.30 | -794.03 | -775.57 | -661.12 | -652.07 | -311.69 | -188.29 | -174.74 | -162.03 | -210.08 | -317.44 | -352.80 | -430.15 | -616.64 | -819.28 | -1,165.03 | -1,194.20 | -1,054.79 | -287.06 |
| Interest Expense | -4 | -4 | -4 | -3 | -3 | -3 | -3 | -2 | -2 | -2 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -4.68 | -6.71 | -8.98 | -9.16 | -7.66 | -9.31 | -10.85 | -14.42 | -12.70 | -17.84 | -21.93 | -34.60 | -36.60 | -33.55 | -44.92 | -10.12 | -9.27 | -11.68 | -4.96 | |
| % of Revenue | -68.47 | -58.01 | -49.65 | -40.79 | -30.43 | -26.00 | -12.08 | -6.92 | -5.49 | -4.42 | -4.28 | -4.70 | -3.26 | -2.53 | -2.35 | -1.67 | -2.24 | -2.22 | -1.89 | -0.75 |
| Net Income | -71 | -64 | -66 | -72 | -72 | -76 | -76 | -70 | -69 | -69 | -70 | -73 | -75 | -73 | -74 | -77 | -77 | -70 | -77 | -54 |
| Change (%) | -10.67 | 3.95 | 8.00 | 0.56 | 5.95 | -0.81 | -6.87 | -2.26 | 0.89 | 0.83 | 4.14 | 3.48 | -3.47 | 2.11 | 3.63 | -0.50 | -8.84 | 9.51 | -29.15 | |
| % of Revenue | -1,161.03 | -921.97 | -879.31 | -856.96 | -707.79 | -693.91 | -352.49 | -211.09 | -191.34 | -178.01 | -211.41 | -309.89 | -339.32 | -401.57 | -572.81 | -766.20 | -1,137.64 | -1,133.04 | -1,195.86 | -351.92 |
Source: Capital IQ
